Cancer

Nullifying protein YTHDF1 enhances anti-tumor response

Cancer immunotherapy—an approach that removes the barriers that protect cancer cells from a patient's immune system—has revolutionized the treatment of many cancer types. About 40 percent of melanoma patients, for example, ...

Alzheimer's disease & dementia

Neuronal cytoskeletons involved in Alzheimer's disease

A researcher at the UPV/EHU participated in a study describing the loss of dynamics and subsequent impairment of the dendritic spines in Alzheimer's disease. Dendritic spines are the compartments of neurons responsible for ...

Immunology

Scientists tackle two distinct immunological disorders

In two recent studies, a team of scientists reports the mechanisms underlying two distinct immunological disorders affecting children and adults. Stephanie Humblet-Baron (VIB-KU Leuven) was the researcher at the helm of both ...

Immunology

Scientists find molecular 'switch' for allergic asthma treatment

A team of Russian scientists has identified the role of the interleukin-6 molecule in the development of allergic asthma. It may comprise a new target for the treatment of this disease. The results are published in Frontiers ...

Cancer

A code for reprogramming immune sentinels

For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

page 2 from 23